In accordance with the report on renoprotection of JPYS formula on anti-inflammation (Chen et al., 2018), we found that JPYS formula relieved inflammatory injury in CKD mice by inhibiting the activation of NF-κB pathway via loss in the kidney. Here, NFKB1 is linked to chronic kidney disease.